Coding

Sex

Age

Survival and cause of death

BMI^a

Tumor type

Immune checkpoint inhibitor

Onset cycle

Coding

1

M

77

Survived

20.83

Non-small cell carcinoma of lung

Carrilizumab

Cycle 8

1

2

F

59

Death. Died of tumor recurrence

23.34

Small cell carcinoma of lung

Letter dilizumab

Cycle 7

2

3

M

69

Survived

15.81

Squamous-cell carcinoma

Triplezumab

Cycle 6

3

4

M

68

Death. Died of respiratory failure

20.76

Non-small cell carcinoma of lung

Carrilizumab

Cycle 1

4

5

F

33

Survived

37.65

Malignant neoplasm of breast

Triplezumab

Cycle 4

5